Annual report pursuant to Section 13 and 15(d)

Income Tax (Tables)

v3.23.3
Income Tax (Tables)
12 Months Ended
Aug. 31, 2023
Income Tax  
Schedule of Income Tax

 

 

August 31

 2023

 

 

August 31

 2022

 

 

 

$

 

 

$

 

Loss before taxes

 

 

(6,712,525 )

 

 

(7,383,653 )

Expected income tax recovery

 

 

(1,427,529 )

 

 

(1,619,854 )

Non-deductible items

 

 

(831 )

 

 

(280,155 )

Change in estimates

 

 

4,271

 

 

 

(44,867 )

Effect of changes in foreign and long-term tax rates

 

 

-

 

 

 

23,625

 

Change in valuation allowance

 

 

1,432,305

 

 

 

1,921,251

 

Total income taxes

 

 

8,216

 

 

 

-
Schedule of Deferred tax assets

 

 

August 31

 2023

 

 

August 31

 2022

 

 

 

$

 

 

$

 

Non-capital losses

 

 

8,637,353

 

 

 

7,747,485

 

Marketable securities

 

 

(14,051 )

 

 

118,175

 

Stock based compensation

 

 

650,778

 

 

 

-

 

R&D

 

 

371,326

 

 

 

-

 

PPE and intangibles

 

 

(64,569 )

 

 

-

 

Total deferred tax assets                 

 

 

9,580,837

 

 

 

7,865,660

 

Valuation Allowance

 

 

(9,580,837 )

 

 

(7,865,660 )

Net Deferred tax assets                 

 

 

-

 

 

 

-

 

 

The Company has net operating loss carry-forwards of approximately $40 million which may be carried forward to apply against future year income tax for U.S. tax purposes.